[
  {
    "ts": null,
    "headline": "Marjorie Taylor Greene Loads Up On Six-Figure Treasury Bill— Diversifies Portfolio With Bitcoin ETF, Tech Stocks",
    "summary": "Rep. Marjorie Taylor Greene (R-Ga.) made a significant six-figure investment into a U.S. Treasury Bill in mid-September, anchoring a flurry of trading activity that also saw her purchase shares in popular technology stocks and a Bitcoin ETF. The ...",
    "url": "https://finnhub.io/api/news?id=8db24e35778a5077962dd57d5c106f2eb6283d78c3d6cbde959e497c4c2cfba1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759361446,
      "headline": "Marjorie Taylor Greene Loads Up On Six-Figure Treasury Bill— Diversifies Portfolio With Bitcoin ETF, Tech Stocks",
      "id": 136952009,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Rep. Marjorie Taylor Greene (R-Ga.) made a significant six-figure investment into a U.S. Treasury Bill in mid-September, anchoring a flurry of trading activity that also saw her purchase shares in popular technology stocks and a Bitcoin ETF. The ...",
      "url": "https://finnhub.io/api/news?id=8db24e35778a5077962dd57d5c106f2eb6283d78c3d6cbde959e497c4c2cfba1"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500, Dow Reach New Peaks as Traders Look Past Ongoing Shutdown",
    "summary": "The S&P 500 and the Dow Jones Industrial Average hit new record highs on Wednesday as traders appear",
    "url": "https://finnhub.io/api/news?id=46463ae646d7ca61aa8571ec1d7bcf123f5787c7df74df4a1cce9896692a2f53",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759352755,
      "headline": "S&P 500, Dow Reach New Peaks as Traders Look Past Ongoing Shutdown",
      "id": 136951001,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "The S&P 500 and the Dow Jones Industrial Average hit new record highs on Wednesday as traders appear",
      "url": "https://finnhub.io/api/news?id=46463ae646d7ca61aa8571ec1d7bcf123f5787c7df74df4a1cce9896692a2f53"
    }
  },
  {
    "ts": null,
    "headline": "Drug Stock Rally Helps Push Dow and S&P 500 to Records",
    "summary": "Pharma stocks climbed for a second session, extending gains that began after President  Trump  unveiled a direct-to-consumer website for Americans to buy drugs.  Amgen  and  Merck  both climbed more than 5%, to push the Dow Jones Industrial Average up 0.1% to its second straight record.  Thermo Fisher Biogen  and  Eli Lilly  were among the top gainers in the S&P 500, which added 0.3%.",
    "url": "https://finnhub.io/api/news?id=5bd585c49d43673b5051763e94a1a7fc8e306395cab56ea3da2dff38efde8a23",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759352100,
      "headline": "Drug Stock Rally Helps Push Dow and S&P 500 to Records",
      "id": 136952143,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Pharma stocks climbed for a second session, extending gains that began after President  Trump  unveiled a direct-to-consumer website for Americans to buy drugs.  Amgen  and  Merck  both climbed more than 5%, to push the Dow Jones Industrial Average up 0.1% to its second straight record.  Thermo Fisher Biogen  and  Eli Lilly  were among the top gainers in the S&P 500, which added 0.3%.",
      "url": "https://finnhub.io/api/news?id=5bd585c49d43673b5051763e94a1a7fc8e306395cab56ea3da2dff38efde8a23"
    }
  },
  {
    "ts": null,
    "headline": "US Equity Indexes Rise as Healthcare Jumps, October Rate-Cut Certainty Increases Amid Surprise Fall in Private Payrolls",
    "summary": "US equity indexes rose at the close on Wednesday amid gains in healthcare and increasing bets favori",
    "url": "https://finnhub.io/api/news?id=2773ac517cad9f7334b97c8ca3bc6e16ed94b3b558af0a0f32ccb9433f36b485",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759351970,
      "headline": "US Equity Indexes Rise as Healthcare Jumps, October Rate-Cut Certainty Increases Amid Surprise Fall in Private Payrolls",
      "id": 136952242,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "US equity indexes rose at the close on Wednesday amid gains in healthcare and increasing bets favori",
      "url": "https://finnhub.io/api/news?id=2773ac517cad9f7334b97c8ca3bc6e16ed94b3b558af0a0f32ccb9433f36b485"
    }
  },
  {
    "ts": null,
    "headline": "Why Are Amgen (AMGN) Shares Soaring Today",
    "summary": "Shares of biotech company Amgen (NASDAQ:AMGN) jumped 6.4% in the afternoon session after the company announced a $650 million investment to expand its US manufacturing network. The investment is aimed at increasing drug production at its biologics facility in Juncos and is expected to create nearly 750 new jobs, including highly skilled manufacturing roles. According to CEO Robert A. Bradway, the expansion highlights Amgen's commitment to US biomanufacturing and strengthening its global supply c",
    "url": "https://finnhub.io/api/news?id=26dfe60d2e96fa2c67c84b99ade81468a86e18ebc0bad3d207d8e6f385b331ee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759348844,
      "headline": "Why Are Amgen (AMGN) Shares Soaring Today",
      "id": 136952330,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Shares of biotech company Amgen (NASDAQ:AMGN) jumped 6.4% in the afternoon session after the company announced a $650 million investment to expand its US manufacturing network. The investment is aimed at increasing drug production at its biologics facility in Juncos and is expected to create nearly 750 new jobs, including highly skilled manufacturing roles. According to CEO Robert A. Bradway, the expansion highlights Amgen's commitment to US biomanufacturing and strengthening its global supply c",
      "url": "https://finnhub.io/api/news?id=26dfe60d2e96fa2c67c84b99ade81468a86e18ebc0bad3d207d8e6f385b331ee"
    }
  },
  {
    "ts": null,
    "headline": "Healthcare Helps Lift US Equity Indexes After Federal Shutdown Begins",
    "summary": "US equity indexes rose ahead of the close on Wednesday amid strong gains in the healthcare sector an",
    "url": "https://finnhub.io/api/news?id=26f967bc0e65373ca871110fb9a6f5a71e2f2cb3b47c5951634e8317d6bd24b4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759348643,
      "headline": "Healthcare Helps Lift US Equity Indexes After Federal Shutdown Begins",
      "id": 136952244,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "US equity indexes rose ahead of the close on Wednesday amid strong gains in the healthcare sector an",
      "url": "https://finnhub.io/api/news?id=26f967bc0e65373ca871110fb9a6f5a71e2f2cb3b47c5951634e8317d6bd24b4"
    }
  },
  {
    "ts": null,
    "headline": "Equities Rise Intraday as Markets Look Past Shutdown",
    "summary": "US benchmark equity indexes rose intraday as traders appeared to look past a federal government shut",
    "url": "https://finnhub.io/api/news?id=086767a9660837a406fab452a5b0cc67fe4dd2e002f497725a26a124b909e4f7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759343791,
      "headline": "Equities Rise Intraday as Markets Look Past Shutdown",
      "id": 136951005,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "US benchmark equity indexes rose intraday as traders appeared to look past a federal government shut",
      "url": "https://finnhub.io/api/news?id=086767a9660837a406fab452a5b0cc67fe4dd2e002f497725a26a124b909e4f7"
    }
  },
  {
    "ts": null,
    "headline": "US Equity Indexes Mixed Amid Healthcare Gains While Treasury Yields Drop as Partial Shutdown Begins",
    "summary": "US equity indexes were mixed in midday trading on Wednesday as healthcare helped offset losses, whil",
    "url": "https://finnhub.io/api/news?id=61675de07f152141193b70daa10b4e4341d46e83bbed41139e9ff6a4533b822a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759340871,
      "headline": "US Equity Indexes Mixed Amid Healthcare Gains While Treasury Yields Drop as Partial Shutdown Begins",
      "id": 136952246,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "US equity indexes were mixed in midday trading on Wednesday as healthcare helped offset losses, whil",
      "url": "https://finnhub.io/api/news?id=61675de07f152141193b70daa10b4e4341d46e83bbed41139e9ff6a4533b822a"
    }
  },
  {
    "ts": null,
    "headline": "Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff",
    "summary": "Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff",
    "url": "https://finnhub.io/api/news?id=9f9a81f312949ff19ddc70aa74d44881bfeb443dc6879b0033db0ff2c6139bbc",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759336566,
      "headline": "Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff",
      "id": 136995449,
      "image": "",
      "related": "AMGN",
      "source": "DowJones",
      "summary": "Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff",
      "url": "https://finnhub.io/api/news?id=9f9a81f312949ff19ddc70aa74d44881bfeb443dc6879b0033db0ff2c6139bbc"
    }
  },
  {
    "ts": null,
    "headline": "2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi",
    "summary": "The global dermatology market is driven by increasing skin disorder prevalence, aging demographics, and technological innovations like teledermatology and nanotechnology. The influence of social media, emerging middle-class markets, and advancements in biologics and transdermal patches also present significant growth opportunities.Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The \"Dermatology Treatment and Care Market With Impact Analysis of US Tariffs (2025 Edition)\" report has been added to Resear",
    "url": "https://finnhub.io/api/news?id=d7e68261cb613c26641b6be3775103fee153cf86174ed801f8f74c35996a6fb1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759325460,
      "headline": "2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi",
      "id": 136947247,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "The global dermatology market is driven by increasing skin disorder prevalence, aging demographics, and technological innovations like teledermatology and nanotechnology. The influence of social media, emerging middle-class markets, and advancements in biologics and transdermal patches also present significant growth opportunities.Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The \"Dermatology Treatment and Care Market With Impact Analysis of US Tariffs (2025 Edition)\" report has been added to Resear",
      "url": "https://finnhub.io/api/news?id=d7e68261cb613c26641b6be3775103fee153cf86174ed801f8f74c35996a6fb1"
    }
  },
  {
    "ts": null,
    "headline": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
    "summary": "Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.",
    "url": "https://finnhub.io/api/news?id=fb5ed6c610a1e722a06f2f01ba2468f753b4201cfbfb6f51a339d7a28ee13c05",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759323604,
      "headline": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
      "id": 136947439,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.",
      "url": "https://finnhub.io/api/news?id=fb5ed6c610a1e722a06f2f01ba2468f753b4201cfbfb6f51a339d7a28ee13c05"
    }
  },
  {
    "ts": null,
    "headline": "Amgen, Merck share gains lead Dow's 119-point jump",
    "summary": "Amgen, Merck share gains lead Dow's 119-point jump",
    "url": "https://finnhub.io/api/news?id=75527ed925ad7bfc9fca5a9f79566e76ec24ffde4704eebc3262e39a9f8e0ed7",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759319100,
      "headline": "Amgen, Merck share gains lead Dow's 119-point jump",
      "id": 136996409,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen, Merck share gains lead Dow's 119-point jump",
      "url": "https://finnhub.io/api/news?id=75527ed925ad7bfc9fca5a9f79566e76ec24ffde4704eebc3262e39a9f8e0ed7"
    }
  },
  {
    "ts": null,
    "headline": "Immatics Appoints Venkat Ramanan as Chief Financial Officer",
    "summary": "Houston, Texas and Tuebingen, Germany, October 1, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in precision targeting of PRAME, today announced the appointment of Venkat Ramanan, Ph.D., as Chief Financial Officer (“CFO”), effective immediately. Dr. Ramanan is a seasoned financial leader in the biopharmaceutical industry with over 25 years of experience at companies including Seagen, Gilead Sciences and Amgen. H",
    "url": "https://finnhub.io/api/news?id=f3a8b72fa762162bd3b59636b253655a37df2d960060e0b9431f44c3cc406dcd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759316400,
      "headline": "Immatics Appoints Venkat Ramanan as Chief Financial Officer",
      "id": 136944222,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Houston, Texas and Tuebingen, Germany, October 1, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in precision targeting of PRAME, today announced the appointment of Venkat Ramanan, Ph.D., as Chief Financial Officer (“CFO”), effective immediately. Dr. Ramanan is a seasoned financial leader in the biopharmaceutical industry with over 25 years of experience at companies including Seagen, Gilead Sciences and Amgen. H",
      "url": "https://finnhub.io/api/news?id=f3a8b72fa762162bd3b59636b253655a37df2d960060e0b9431f44c3cc406dcd"
    }
  }
]